After speaking on Thursday at American Associated Pharmacies’ Annual Conference in San Diego, NCPA CEO Douglas Hoey sat down with Drug Topics’ Killian Meara to talk about what independent pharmacies are dealing with lately, including the DIR hangover and the urgent need for PBM reform. “There are lots of ways for Congress and CMS to take action,” Hoey told Meara, citing alarming NCPA survey results demonstrating that many independent pharmacies are running out of time.